About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

How To Improve Antibody Targeting In Cancer Treatment?

by Pooja Shete on January 11, 2021 at 12:32 PM
Font : A-A+

How To Improve Antibody Targeting In Cancer Treatment?

Scientists have gained new insight on how the immune system can be better used to find and kill cancer cells. They showed that antibodies which are designed to target the molecule OX40, give a more active immune response when they bind closer to the cell membrane and can be modified to attack cancer in different ways.

The research conducted by Professor Mark Cragg and Dr Jane Willoughby from the Antibody and Vaccine Group at the University of Southampton's Centre for Cancer Immunology along with BioInvent International is published in the Journal for ImmunoTherapy of Cancer.

Advertisement


During an immune response, OX40 is a 'co-receptor' that helps to stimulate the production of helper and killer T-cells. The cancer cells avoid the detection by suppressing immune responses to stop functional tumor specific T-cells from being produced.

In the study, the team found that switching the antibody's isotype (the part of the antibody that engages with cells of the immune system) could change the way the antibody worked. By using the mIgG2a isotype, the antibody could delete cells called Treg cells which are suppressive in the immune system. In the presence of mIgG1 isotype, the antibody could stimulate killer T-cells to increase and therefore kill more cancer cells.
Advertisement

Professor Cragg said, "Clinical trials with anti-OX40 antibodies have shown that the body can tolerate these drugs but unfortunately have also shown disappointing clinical responses. We need to understand why this is. This new data shows us that when there is a cancer with lots of Tregs we could use the equivalent of the m2IgGa isotype and in patients where we feel we need better cytotoxic T cells we could use the equivalent of a mIgG1 isotype to boost the immune response. This information is important for developing the next generation of OX40 antibodies that we hope will be more effective in treating patients with cancer."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Monkeypox Outbreak: What it is, How Does it Spread & the Prevention
Seasonal Allergy Medications
How to Choose the Best Eczema-Friendly Moisturizer for Children?
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Neck Cracking Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Most Popular on Medindia

Pregnancy Confirmation Calculator Loram (2 mg) (Lorazepam) Sanatogen A-Z Drug Brands in India Selfie Addiction Calculator The Essence of Yoga Blood Donation - Recipients Daily Calorie Requirements Drug - Food Interactions Indian Medical Journals

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE